Table 2.
Summary of adverse events.
| 5-ALA-SFC n = 35 |
Placebo n = 18 |
|
|---|---|---|
| Subjects reporting at least one event∗ | 16 (45.7%) | 5 (27.8%) |
| Subjects reporting at least one related event | 7 (20%) | 3 (16.7%) |
| Subjects reporting at least one severe event | 0 | 0 |
| Subjects reporting at least one event leading to study discontinuation | 6 (17.1%) | 1 (5.6%) |
∗ p = 0.206.